Proteomics

Dataset Information

0

Proteomic profiling identifies ITIH3 as a biomarker for disease activity in myasthenia gravis


ABSTRACT: Myasthenia gravis (MG) is a chronic antibody-mediated autoimmune disease disrupting neuromuscular synaptic transmission. Antibodies (Abs) against the acetylcholine receptor (AChR) are detected in approximately 85% of patients. Here, we aimed to study the serum proteome of MG and to identify novel biomarkers reflecting disease activity.

INSTRUMENT(S): Synapt MS

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Andreas Hentschel  

LAB HEAD: Tobias Ruck

PROVIDER: PXD040786 | Pride | 2023-10-24

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
proc_data_V3.xlsx Xlsx
schroeter12740.raw.7z Raw
schroeter12776.raw.7z Raw
schroeter12963.raw.7z Raw
schroeter12980.raw.7z Raw
Items per page:
1 - 5 of 256
altmetric image

Publications


Therapeutic strategies targeting complement have revolutionized the treatment of myasthenia gravis (MG). However, a deeper understanding of complement modulation in the human system is required to improve treatment responses and identify off-target effects shaping long-term outcomes. For this reason, we studied a cohort of patients with MG treated with either eculizumab or azathioprine as well as treatment-naive patients using a combined proteomics and metabolomics approach. This strategy valida  ...[more]

Similar Datasets

2009-12-08 | E-MEXP-2480 | biostudies-arrayexpress
2016-08-10 | E-GEOD-80678 | biostudies-arrayexpress
2012-04-15 | E-MEXP-3185 | biostudies-arrayexpress
2010-08-01 | E-MEXP-2716 | biostudies-arrayexpress
2022-02-16 | PXD029398 | Pride
2010-12-01 | E-MEXP-2501 | biostudies-arrayexpress
2015-03-12 | E-MEXP-3666 | biostudies-arrayexpress
2008-06-26 | E-MEXP-1530 | biostudies-arrayexpress
2020-11-03 | PXD017211 | Pride
2021-06-07 | PXD023508 | Pride